- Tillerson confronts North Korea at UN
- Elysee plays down opulence of Macron birthday at Loire chateau
- Argentina fires head of navy over submarine tragedy
- Egyptian presidential hopeful apologizes to arrested supporters
- Argentina fires head of navy after submarine tragedy
- Canadian police probe mysterious deaths of billionaire pharma couple
- Nazareth Christmas celebrations will be held as normal: mayor
- Libyan coast guard rescues more than 250 migrants trying to reach Ital
- It looks like tax reform is already paying off with the GOP base
- Thousands of Romanians mourn former king Michael
- Sexual harassment allegations swirl around ESPN
- Report: Toronto billionaire and his wife found dead in their home
- Austrian conservatives bring far right into government
- Russian and French foreign ministers discussed situation in Syria
- Australian PM future safeguarded in crucial Sydney by-election
- Palestinian billionaire Masri detained in Saudi Arabia: sources
- Myanmar journalists' group to don black T-shirts over arrest of Reuter
- Dustin Hoffman accused of sexual assault
- Facebook worries it might be bad for you, adds a mute button
- U.S. says did everything possible to help Italy cyber investigation
Hungary's Richter sees no link between liver damage and Esmya medicine
BUDAPEST (Reuters) - Hungarian drugmaker Richter’s clinical data indicate no demonstrable link between liver damage cases and treatment with its uterine fibroid medicine Esmya, the firm said on Monday.
The European Medicines Agency (EMA) has started a review of Esmya after four reports of serious liver injury, three of which ended in liver transplantation, in patients treated with the medicine.
“Based on the clinical data at our disposal, we consider that there is no demonstrable link between liver damage and treatment with Esmya,” spokeswoman Zsuzsa Beke said, adding that Richter believed the product should not be suspended.
Reporting by Gergely Szakacs and Marton Dunai; Editing by Edmund Blair
Our Standards:The Thomson Reuters Trust Principles.